At-home health testing subscription
Scaling Meta Ads While Increasing Spend Efficiency
Restructured targeting and consolidated onto winning creative to cut CPC 26% while scaling spend 260%.
- Product
- At-home health testing subscription
- Model
- Annual subscription at $180/yr
- Timeframe
- 8 months
Results
+260%
Ad spend scaled
+26%
CPC efficiency


The situation
Clicks cost too much for the paid engine to pay for itself, so the account had been held small. Spend could not go up without LTV:CAC going down.


What we did
- Consolidated fragmented targeting into a few broad ad sets
- Budget was split across enough audiences that no single ad set gathered the conversion volume Meta needs to optimize against
- Fewer and broader lets the algorithm find the buyer rather than being told where to look
- Moved budget onto the winning creative and kept iterating on it
- Creative carries the targeting now: a different message per ICP is the signal the algorithm acts on
- The territories were built on value props users had voted for, not on what the team wanted to say
- Scaled in steps, reading cost per link click at every one
- Spend tripled by month two, came back down through the spring, then ran at three to five times the starting level from month six on
- Cost per link click fell from $1.60 to $0.85 at its cheapest, and held at $1.20 with spend near its peak




Scaling spend usually costs you efficiency. Here it went the other way: a cleaner targeting structure and relentless consolidation onto the creative that worked let spend grow 260% while CPC actually improved.
Want results like this?
We help consumer apps and products reach their next phase of growth.
Related notes
More case studies
~$30MM incremental revenue / quarter
A CRO Program That Consistently Beats Benchmarks
+50% self-serve conversion
Building B2B Product-Led Growth From Zero
2.7x paid ltv:cac
Nearly Tripling Paid LTV:CAC in Four Months
3.1x monthly ad spend, to $276k
Scaling Ad Spend 3x and Reaching Profitability in Seven Months
Growth notes, in your inbox
New writing on subscription growth and product-led strategy when I have something worth saying. No spam.